• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Research Briefing on 7-Bromo-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbonitrile (CAS: 884507-59-9)

In recent years, the compound 7-Bromo-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbonitrile (CAS: 884507-59-9) has garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic compound, characterized by its unique thienodioxine scaffold, has shown promising potential in various applications, including drug discovery, material science, and organic synthesis. The presence of both bromo and cyano functional groups enhances its reactivity, making it a versatile intermediate for further chemical modifications.

Recent studies have focused on the synthesis and optimization of 7-Bromo-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbonitrile to improve its yield and purity. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound and confirm its structural integrity. Researchers have also explored its potential as a building block for the development of novel pharmaceuticals, particularly in the design of kinase inhibitors and other therapeutic agents targeting metabolic disorders.

One of the key findings from recent research is the compound's role in the synthesis of polycyclic aromatic hydrocarbons (PAHs) and conjugated polymers. These materials have applications in organic electronics, including organic light-emitting diodes (OLEDs) and photovoltaic cells. The electron-withdrawing nature of the cyano group in 7-Bromo-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbonitrile contributes to the tuning of electronic properties, making it a valuable component in the development of advanced materials.

In the pharmaceutical domain, preliminary in vitro studies have demonstrated the compound's ability to modulate specific biological pathways. For instance, it has been investigated as a potential inhibitor of protein kinases involved in inflammatory responses and cancer progression. While further in vivo studies are required to validate these findings, the initial results highlight the compound's therapeutic potential and warrant continued exploration.

In conclusion, 7-Bromo-2,3-dihydrothieno[3,4-b][1,4]dioxine-5-carbonitrile (CAS: 884507-59-9) represents a promising candidate for both chemical and biological applications. Its versatility as a synthetic intermediate and its potential therapeutic benefits make it a subject of ongoing research. Future studies should focus on optimizing its synthesis, elucidating its mechanism of action, and exploring its applications in drug development and material science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)